Gary J Macfarlane
Overview
Explore the profile of Gary J Macfarlane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
251
Citations
5720
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lam A, Hueniken K, Pienkowski M, Lee J, Dong M, Diergaarde B, et al.
JAMA Otolaryngol Head Neck Surg
. 2025 Feb;
PMID: 39976935
Importance: Cigarette smoking is a strong risk factor for mortality in patients diagnosed with head and neck squamous cell carcinoma (HNSCC). However, little evidence supports which smoking metric best models...
2.
Hudson J, Imamura M, Robertson C, Whibley D, Aucott L, Gillies K, et al.
Arthritis Care Res (Hoboken)
. 2025 Feb;
PMID: 39930945
Clinical Context: Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain and fatigue. Almost everyone with fibromyalgia has sleep problems. Objective: We aimed to evaluate the effectiveness and safety...
3.
Pons M, Georgiadis S, Hetland M, Faizy Ahmadzay Z, Rasmussen S, Christensen S, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892891
Objective: In patients with axial spondyloarthritis (axSpA) initiating secukinumab (SEC), we aimed to identify baseline (treatment start) predictors of achieving low disease activity (LDA) after 6 months, as measured by...
4.
Ciurea A, Kissling S, Gotschi A, Ornbjerg L, Rasmussen S, Tamasi B, et al.
Arthritis Res Ther
. 2025 Jan;
27(1):18.
PMID: 39891200
Background: Efficacy of tumour necrosis factor inhibitors (TNFi) for peripheral arthritis in patients with psoriatic arthritis (PsA) has been established in randomized clinical trials that have used improvement in summated...
5.
Ahmadzay Z, Heberg J, Jorgensen J, Ornbjerg L, Ostergaard M, Moller-Bisgaard S, et al.
Rheumatol Adv Pract
. 2024 Nov;
8(4):rkae135.
PMID: 39611201
Objectives: Real-world evidence is needed to inform treatment strategies for patients with PsA and axial SpA (axSpA) who have non-musculoskeletal manifestations (NMMs), various risk factors and comorbidities. International collaboration is...
6.
Pons M, Georgiadis S, Ostergaard M, Faizy Ahmadzay Z, Glintborg B, Heberg J, et al.
Joint Bone Spine
. 2024 Nov;
92(3):105824.
PMID: 39608666
Objectives: In axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) patients initiating secukinumab, we aimed to assess retention rates and proportions of patients achieving remission and low disease activity (LDA), according...
7.
Timmins K, Hales T, Macfarlane G
Pain
. 2024 Nov;
PMID: 39499541
Evidence linking adverse childhood experiences and chronic pain in adulthood is largely cross-sectional, potentially subject to recall bias and does not allow exploration of mediating pathways. We analysed a large...
8.
Thakral A, Lee J, Hou T, Hueniken K, Dudding T, Gormley M, et al.
Nat Commun
. 2024 Sep;
15(1):7835.
PMID: 39244563
HPV-positive and HPV-negative head and neck squamous cell carcinoma (HNSCC) are recognized as distinct entities. There remains uncertainty surrounding the causal effects of smoking and alcohol on the development of...
9.
Christiansen S, Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, et al.
RMD Open
. 2024 Jul;
10(3.
PMID: 39053949
Objectives: To compare the treatment effectiveness of secukinumab in radiographic (r) versus non-radiographic (nr) axial spondyloarthritis (axSpA) patients treated in routine care across Europe. Methods: Prospectively collected data on secukinumab-treated...
10.
Sneddon J, Macfarlane G, Jones G, Moir L, Parr R, Jenkins D, et al.
JAC Antimicrob Resist
. 2024 Jul;
6(4):dlae107.
PMID: 39035019
The UK Antimicrobial Registry (UKAR) has been developed to capture data on real world usage of antimicrobial agents with an initial focus on those used to treat drug-resistant infections. Several...